This Article Order Full text via Infotrieve Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Stahle-Backdhal, M. Articles by Friedman, E. Search for Related Content PubMed PubMed Citation Articles by Stahle-Backdhal, M. Articles by Friedman, E.

American Journal of Pathology, Vol 146, 1073-1078, Copyright © 1995 by American Society for Investigative Pathology

REGULAR ARTICLES

Decreased expression of Ras GTPase activating protein in human trophoblastic tumors

M Stahle-Backdhal, M Inoue, J Zedenius, B Sandstedt, L DeMarco, F Flam, C Silfversward, J Andrade and E Friedman
Department of Dermatology, Karolinska Hospital, Stockholm, Sweden.

The normally developing placenta undergoes extensive but regulated noninvasive cellular proliferation. Various proto-oncogenes and growth factors have been associated with the regulation of trophoblastic placental growth. Activation of some oncogenes and altered expression of growth factors have been demonstrated in trophoblastic tumors (hydatidiform mole and choriocarcinoma). The ras proto-oncogene plays a key role in the signal transduction cascade of activated growth factors, and is known to be activated or overexpressed in multiple tumor types. Ras GTPase activating protein (RasGAP), a major down- regulator of ras activity, is present at high levels in placenta. To assess the role that Ras-GAP plays in the development of trophoblastic tumors, we performed immunohistochemical analyses with anti RasGAP antibodies of normal placentas, hydatidiform moles, invasive moles, and malignant choriocarcinomas. Normal placentas and noninvasive hydatidiform mole displayed intense positive staining confined to trophoblasts, whereas no staining was observed in the trophoblasts of invasive moles or choriocarcinomas. Thus, there was an inverse correlation between expression levels of RasGAP protein and the invasive potential and malignant phenotype in human trophoblastic tumors. The data indicate that RasGAP may play a regulatory role in trophoblast proliferation and that abolishing its activity may be associated with malignant transformation of these cells.

This article has been cited by other articles:

				I.-M. Shih and K.-T. Kuo Power of the Eternal Youth: Nanog Expression in the Gestational Choriocarcinoma Am. J. Pathol., October 1, 2008; 173(4): 911 - 914. [Abstract] [Full Text] [PDF]

				S C C Wong, A T C Chan, J K C Chan, and Y M D Lo Nuclear {beta}-catenin and Ki-67 expression in choriocarcinoma and its pre-malignant form J. Clin. Pathol., April 1, 2006; 59(4): 387 - 392. [Abstract] [Full Text] [PDF]

				W.-C. Xue, K. Y.K. Chan, H.-C. Feng, P.-M. Chiu, H. Y.S. Ngan, S.-W. Tsao, and A. N.Y. Cheung Promoter Hypermethylation of Multiple Genes in Hydatidiform Mole and Choriocarcinoma J. Mol. Diagn., November 1, 2004; 6(4): 326 - 334. [Abstract] [Full Text] [PDF]

				B. Bartling, J.-Y. Yang, D. Michod, C. Widmann, R. Lewensohn, and B. Zhivotovsky RasGTPase-activating protein is a target of caspases in spontaneous apoptosis of lung carcinoma cells and in response to etoposide Carcinogenesis, June 1, 2004; 25(6): 909 - 921. [Abstract] [Full Text] [PDF]